Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Death, Sudden, Cardiac | 6 | 2024 | 1568 | 0.300 |
Why?
|
| Tetrazoles | 4 | 2015 | 922 | 0.220 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2024 | 2145 | 0.170 |
Why?
|
| Diabetic Angiopathies | 2 | 2015 | 806 | 0.170 |
Why?
|
| Heart Failure | 11 | 2024 | 11857 | 0.170 |
Why?
|
| Myocardial Infarction | 8 | 2024 | 11515 | 0.170 |
Why?
|
| Diabetic Nephropathies | 2 | 2015 | 975 | 0.150 |
Why?
|
| Kidney Transplantation | 3 | 2018 | 4285 | 0.150 |
Why?
|
| Cardiovascular Diseases | 9 | 2018 | 15638 | 0.130 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2010 | 429 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2024 | 1518 | 0.110 |
Why?
|
| Enalapril | 1 | 2015 | 316 | 0.110 |
Why?
|
| Sulfonamides | 3 | 2008 | 1988 | 0.100 |
Why?
|
| Troponin I | 1 | 2017 | 662 | 0.100 |
Why?
|
| Hematinics | 1 | 2015 | 282 | 0.100 |
Why?
|
| Pyrazoles | 3 | 2008 | 2024 | 0.100 |
Why?
|
| Benzimidazoles | 2 | 2007 | 864 | 0.090 |
Why?
|
| Erythropoietin | 1 | 2015 | 719 | 0.090 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2010 | 48 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 809 | 0.090 |
Why?
|
| Ventricular Fibrillation | 2 | 2011 | 537 | 0.080 |
Why?
|
| Cause of Death | 6 | 2017 | 3727 | 0.080 |
Why?
|
| Valine | 1 | 2010 | 410 | 0.080 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2015 | 1066 | 0.080 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 1751 | 0.070 |
Why?
|
| Metformin | 1 | 2016 | 914 | 0.070 |
Why?
|
| Stroke Volume | 3 | 2017 | 5620 | 0.070 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 321 | 0.060 |
Why?
|
| Adenomatous Polyps | 1 | 2005 | 109 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 2 | 2011 | 1309 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2017 | 12242 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 3111 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2017 | 10358 | 0.050 |
Why?
|
| Insulin | 1 | 2016 | 6606 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 2291 | 0.050 |
Why?
|
| Biphenyl Compounds | 3 | 2015 | 1026 | 0.040 |
Why?
|
| Rats, Inbred SHR | 2 | 1997 | 187 | 0.040 |
Why?
|
| Aged | 16 | 2024 | 171520 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2000 | 341 | 0.040 |
Why?
|
| Neoplasms | 2 | 2018 | 22386 | 0.040 |
Why?
|
| Hospitalization | 2 | 2017 | 10845 | 0.040 |
Why?
|
| Tissue Survival | 1 | 1998 | 120 | 0.040 |
Why?
|
| Blood Pressure | 3 | 2006 | 8538 | 0.040 |
Why?
|
| Middle Aged | 15 | 2024 | 223418 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2279 | 0.030 |
Why?
|
| Male | 19 | 2024 | 364781 | 0.030 |
Why?
|
| Colorectal Neoplasms | 2 | 2006 | 6978 | 0.030 |
Why?
|
| Adenoma | 1 | 2006 | 2163 | 0.030 |
Why?
|
| Female | 19 | 2024 | 396943 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2017 | 15880 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1998 | 484 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3122 | 0.030 |
Why?
|
| Resuscitation | 2 | 2011 | 680 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 1996 | 591 | 0.030 |
Why?
|
| Risk Factors | 6 | 2024 | 74915 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6537 | 0.030 |
Why?
|
| North America | 1 | 2016 | 1292 | 0.020 |
Why?
|
| Australia | 1 | 2016 | 1264 | 0.020 |
Why?
|
| Follow-Up Studies | 6 | 2010 | 39430 | 0.020 |
Why?
|
| Humans | 20 | 2024 | 768451 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2006 | 5926 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2015 | 12450 | 0.020 |
Why?
|
| Albuminuria | 1 | 2015 | 658 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2000 | 4202 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2007 | 13030 | 0.020 |
Why?
|
| Aorta | 1 | 1997 | 2046 | 0.020 |
Why?
|
| Europe | 1 | 2016 | 3439 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2015 | 2079 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 1820 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2016 | 894 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1998 | 2258 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12096 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4138 | 0.020 |
Why?
|
| Triglycerides | 1 | 2015 | 2465 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 1996 | 2028 | 0.020 |
Why?
|
| Proportional Hazards Models | 3 | 2006 | 12561 | 0.020 |
Why?
|
| Anemia | 1 | 2016 | 1521 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 2396 | 0.020 |
Why?
|
| Rats, Wistar | 2 | 2000 | 1891 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2016 | 2102 | 0.010 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2006 | 241 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4213 | 0.010 |
Why?
|
| Disease Management | 1 | 2014 | 2533 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 59680 | 0.010 |
Why?
|
| Prognosis | 3 | 2010 | 30028 | 0.010 |
Why?
|
| Risk | 2 | 2005 | 9642 | 0.010 |
Why?
|
| Time Factors | 3 | 2010 | 40271 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3440 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 2489 | 0.010 |
Why?
|
| Placebos | 1 | 2006 | 1668 | 0.010 |
Why?
|
| Rats | 4 | 2000 | 23839 | 0.010 |
Why?
|
| Morbidity | 1 | 2007 | 1760 | 0.010 |
Why?
|
| Safety | 1 | 2006 | 1159 | 0.010 |
Why?
|
| Internationality | 1 | 2007 | 1007 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 2011 | 1498 | 0.010 |
Why?
|
| Sweden | 1 | 2004 | 1382 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6429 | 0.010 |
Why?
|
| Risk Assessment | 3 | 2008 | 24311 | 0.010 |
Why?
|
| Receptor, Endothelin A | 1 | 2000 | 55 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1585 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2014 | 5371 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15460 | 0.010 |
Why?
|
| Comorbidity | 1 | 2014 | 10601 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65409 | 0.010 |
Why?
|
| Canada | 1 | 2004 | 2143 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22293 | 0.010 |
Why?
|
| Hydralazine | 1 | 1996 | 34 | 0.010 |
Why?
|
| Hypertension | 1 | 1996 | 8611 | 0.010 |
Why?
|
| Myocardium | 2 | 2000 | 4788 | 0.010 |
Why?
|
| Captopril | 1 | 1996 | 262 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 1996 | 320 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1998 | 578 | 0.010 |
Why?
|
| Organ Size | 1 | 2000 | 2268 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1996 | 2087 | 0.010 |
Why?
|
| Adult | 3 | 2017 | 223542 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2005 | 1516 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 4526 | 0.010 |
Why?
|
| United States | 2 | 2017 | 73121 | 0.010 |
Why?
|
| Necrosis | 1 | 1998 | 1621 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2015 | 81834 | 0.010 |
Why?
|
| Obesity | 1 | 2016 | 13065 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2000 | 1280 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12875 | 0.010 |
Why?
|
| Stroke | 1 | 2015 | 9791 | 0.010 |
Why?
|
| Remission Induction | 1 | 1996 | 2408 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2015 | 54914 | 0.010 |
Why?
|
| Water | 1 | 1996 | 1421 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 13655 | 0.000 |
Why?
|
| Animals | 4 | 2000 | 169418 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2007 | 41797 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 1996 | 3941 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 9066 | 0.000 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_